Gland Pharma Limited (BOM:543245)

Gland Pharma Revenue

In the fiscal year ending March 31, 2026, Gland Pharma had annual revenue of 64.31B INR with 14.50% growth. Gland Pharma had revenue of 17.43B in the quarter ending March 31, 2026, with 22.31% growth.

• Revenue: 64.31B
• Revenue Growth: +14.50%
• P/S Ratio: 5.93
• Revenue / Employee: 14.78M
• Employees: 4,351
• Market Cap: 381.08B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	64.31B	8.14B	14.50%
Mar 31, 2025	56.17B	-482.18M	-0.85%
Mar 31, 2024	56.65B	20.40B	56.29%
Mar 31, 2023	36.25B	-7.76B	-17.64%
Mar 31, 2022	44.01B	9.38B	27.08%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 27, 2026

Data Sources Report a data error